re rad onc inside
TRANSCRIPT
Pinning Down Tumor Cells’ Resistance to Therapy
Dr. Diehn is working to break down
the cellular defenses of leukemia and
solid cancers.
His research with a breast tumor
model has suggested that the key to
eradicating a cancer is to find and
destroy all of the cancer’s stem cells.
The grant allowed Dr. Diehn protected
time to investigate mechanisms
within those cells that resist chemo-
therapy and radiation therapy.
Better understanding of these mecha-
nisms, fueled by Dr. Diehn’s research,
may help physicians deliver targeted
treatment that can wipe out a cancer
for good.
Dr. Diehn used his promising results
to pursue funding from the National
Institutes of Health and private
foundations. Today, he’s an assistant
professor in the Department of
Radiation Oncology and Institute for
Stem Cell Biology and Regenerative
Medicine at Stanford University. Last
year he contributed to the discovery of
human bladder cancer stem cells and
published evidence of treatment
resistance mechanisms in solid tumor
cancer stem cells.
“In addition to funding the work itself,
I believe that the R&E grant signifi-
cantly strengthened my CV because it
documented that I could successfully
compete for external grant funding,”
said Dr. Diehn. “I think this program
does exactly what it sets out to do.”
Innovations like Dr. Diehn’s are the
real building blocks for medical
breakthroughs that will deliver better
care to patients.
Maximilian Diehn, M.D., Ph.D.Department of Radiation OncologyStanford UniversityR&E Grant Recipient
r&e grants are creating the future. make it a guarantee. donate today.
C
M
Y
CM
MY
CY
CMY
K
Inside RadOnc.eps 1 4/7/10 4:21 PMInside RadOnc.eps 1 4/7/10 4:21 PM